Press release
Diabetes Market to Expand at a Significant Growth Rate During the Forecast Period (2019-32) - Estimates DelveInsight
DelveInsight's "Diabetes Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Diabetes Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).The Diabetes market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Diabetes: An Overview
Diabetes or Diabetes Mellitus (DM) is a chronic metabolic condition characterized by high or low blood glucose (or blood sugar) levels, leading to significant damage to the heart, blood vessels, eyes, kidneys, and nerves over time.
The rationale behind developing diabetes incorporates two factors: insufficient insulin production (produced by the pancreas and reduced blood glucose) or unsatisfactory cell response to insulin action.
Diabetes Market Key Facts
1. As per Juvenile Diabetes Research Foundation (2020), in the UK, approximately 400,000 people are currently living with type 1 diabetes, including around 29,000 children. In children under five, the new type 1 diabetes cases are rising by around 5% each year. Other than this, the number of new diagnoses of type 1 diabetes is increasing by about 4% each year.
2. According to the International Diabetes Federation( 2020), the total prevalence of diabetes in Germany is around 15.3%, which accounts for 9,510,500 adults. It is anticipated that the total cases in the European region will rise to about 68 million by the year 2045.
3. As per the American Diabetes Association (2018), 34.2 million Americans, or around 10.5% of the population, had diabetes, and nearly 1.6 million Americans had type 1 diabetes, including about 187,000 children and adolescents.
Find a sample copy of the Diabetes Market report at:
https://www.delveinsight.com/report-store/diabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Diabetes Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Diabetes market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Diabetes market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Request a sample and discover more about the report offerings @
https://www.delveinsight.com/report-store/diabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Diabetes Epidemiology
The epidemiology section covers detailed insights into the historical and current Diabetes patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.
Explore more about the Diabetes Epidemiology @
https://www.delveinsight.com/report-store/diabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Diabetes Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diabetes market or expected to get launched in the market during the study period. The analysis covers Diabetes market uptake by drugs, patient uptake by therapies, and sales of each drug.
Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Diabetes Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for a sample report to understand more about the Diabetes pipeline development activities @
https://www.delveinsight.com/report-store/diabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Diabetes Therapeutics Assessment
As per DelveInsight, the Diabetes market is expected to grow in the coming years due to the rise in the prevalence of the disease, the rise in novel therapies, increased healthcare spending across the world, and the active participation of the key pharma and biotech companies operating in the therapeutic market.
Some of the Key companies in the Diabetes market include Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, BioRestorative Therapies, Elevian, Kamada, Adocia, Oramed Pharmaceuticals, ImCyse, Histogen, Novo Nordisk, Enthera, ActoBio Therapeutics, Japan Tobacco, Avotres, and many more.
Diabetes Therapies covered in the report include AMA002, AZD9567, TOL-3021, ORMD-0801, AG019, and many others.
Learn more about the emerging therapies & key companies in the Diabetes Therapeutics Market @
https://www.delveinsight.com/report-store/diabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Diabetes Report Key Insights
1. Diabetes Patient Population
2. Diabetes Market Size and Trends
3. Key Cross Competition in the Diabetes Market
4. Diabetes Market Dynamics (Key Drivers and Barriers)
5. Diabetes Market Opportunities
6. Diabetes Therapeutic Approaches
7. Diabetes Pipeline Analysis
8. Diabetes Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Diabetes Market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Diabetes Competitive Intelligence Analysis
4. Diabetes Market Overview at a Glance
5. Diabetes Disease Background and Overview
6. Diabetes Patient Journey
7. Diabetes Epidemiology and Patient Population
8. Diabetes Treatment Algorithm, Current Treatment, and Medical Practices
9. Diabetes Unmet Needs
10. Key Endpoints of Diabetes Treatment
11. Diabetes Marketed Products
12. Diabetes Emerging Therapies
13. Diabetes Seven Major Market Analysis
14. Attribute Analysis
15. Diabetes Market Outlook (7 major markets)
16. Diabetes Access and Reimbursement Overview
17. KOL Views on the Diabetes Market.
18. Diabetes Market Drivers
19. Diabetes Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Get the Detailed TOC of the Diabetes Market report here:
https://www.delveinsight.com/report-store/diabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Market to Expand at a Significant Growth Rate During the Forecast Period (2019-32) - Estimates DelveInsight here
News-ID: 2594174 • Views: …
More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…

Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…

Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…

Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…